Table 2 Univariate analysis for known prognostic factors versus progression of index metastases.

From: Progression of index metastases in oligometastatic hormone-sensitive prostate cancer: implications for metastases directed therapy?

Characteristic

OR (95% CI)

p-value

cN0 vs cN1

1.7 (0.1–22.5)

1.0

M1a vs M1b

3.6 (0.3–46.4)

0.6

GS 1-3 vs 4-5

0.3 (0.01–6.4)

0.4

ADT alone vs intensification

1.7 (0.1–22.5)

1.0

6 m PSA ≤ 0.1 vs >0.1

1.1 (0.08–15.5)

1.0

6 m PSA ≤ 0.2 vs >0.2

0.8 (0.08–8.2)

1.0

Back to article page